FAKTOR OPTIONSSCHEIN - QIAGEN Share Price

Certificat

DE000GX708F3

Market Closed - BOERSE MUENCHEN 19:26:25 29/05/2024 BST
0.558 EUR -5.26% Intraday chart for FAKTOR OPTIONSSCHEIN - QIAGEN
Current month-1.93%
1 month-1.76%
Date Price Change
29/05/24 0.558 -5.26%
28/05/24 0.589 -7.68%
27/05/24 0.638 +1.11%
24/05/24 0.631 +4.99%
23/05/24 0.601 -8.10%

Real-time BOERSE MUENCHEN

Last update May 29, 2024 at 07:26 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying QIAGEN N.V.
Issuer Goldman Sachs
WKN GX708F
ISINDE000GX708F3
Date issued 06/01/2022
Strike 34.42 $
Maturity Unlimited
Parity 13.8 : 1
Emission price 9.99
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 9.92
Lowest since issue 0.342
Spread 0.01
Spread %1.79%

Company Profile

Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.
Sector
-
More about the company

Ratings for Qiagen N.V.

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Qiagen N.V.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
42.58 USD
Average target price
50.14 USD
Spread / Average Target
+17.75%
Consensus